ANALYSIS OF THE RISK FACTORS OF PERINATAL PATHOLOGY IN WOMEN WHO HAD COVID-19 DURING PREGNANCY

Lidiia Melenchuk

doi:10.23856/5658

Lidiia Melenchuk Institute of Hereditary Pathology of the National Academy of Medical Sciences of Ukraine https://orcid.org/0000-0001-5318-9992

Keywords: pregnancy, pregnant women, COVID-19

Abstract

The aim of this study is to look at the impact of COVID-19 on the occurrence of perinatal complications in women who contracted COVID-19 during pregnancy, among the population of the Lviv region. Data on the results of medical and social characteristics, somatic and reproductive anamnesis, and the course of pregnancy of women who contracted COVID-19 during pregnancy (the main group) were analyzed. 20.0% of women who contracted COVID-19 during pregnancy were aged 36 years or older, while there were no women of this age in the control group (p< 0.05). The majority of pregnant women who contracted COVID-19 during pregnancy, namely 68.0% lived in the city, and the majority of healthy pregnant women in the control group lived in rural areas, namely 70.0% (p <0.05). According to social status, a significant part of the women of the main group, namely 30.0% were employed, compared to the women of the control group, where only 16.7% or (p<0.05) were employed. 24.0% of women in the main group had certain peculiarities in their reproductive anamnesis and 52.0% of them had somatic diseases. None of the women in the control group had reproductive or somatic history of complications. All women in the main group had a complicated course of pregnancy, in particular, 30.0% of women had preeclampsia, 28.0% had anemia of various degrees, 52.0% of pregnant women had combined complications, and 16.0% of women had an exacerbation of somatic pathology. In the control group, 90.0% of women did not have a complicated course of pregnancy. The majority of pregnant women (96.0%) fell ill with COVID-19 in the 3rd trimester of pregnancy, and only 4.0% of people – in the 2nd trimester. About half of the women (54.0%) had a mild course of COVID-19, 38.0% of pregnant women had a moderate course of the disease, and 8.0% had a severe course of the disease. Therefore, women over 36 years, living in an urbanized area with somatic pathology and complicated course of pregnancy can be considered as risk factors for perinatal complications for pregnant women with COVID-19.

References

1. Zhylka N.Ya., Slabkyi H.O., Shcherbinska O.S. (2021). Stan reproduktyvnoho zdorovia zhinok v Ukraini [State of reproductive health of women in Ukraine] Reproduktyvna endokrynolohiia. 4(60): 65-69. Аccess mode: https://dspace.uzhnu.edu.ua/jspui/handle/lib/38215 [in Ukrainian].
2. Veropotvelyan P.N. (2017). Reproduktivnoe zdorov'e zhenshchiny – odna iz vazhnejshih problem gosudarstva [The reproductive health of women is one of the most important problems of the state. Medical aspects of women's health]. Medicinskie aspekty zdorov'ya zhenshchiny. 3:34-46. [in Ukrainian].
3. Kovalenko O.S., Lepokhina H.S., Zazarkhov O.Yu., Zlepko S.M. (2016). Klasyfikatsiia ryzykiv perynatalnoho periodu zhyttia novonarodzhenykh [Classification of risks of the perinatal period of life of newborns] Environment & Health. 4: 52-54. [in Ukrainian].
4. Schwartz D.A. (2020). An Analysis of 38 Pregnant Women With COVID-19, Their Newborn Infants, and Maternal-Fetal Transmission of SARS-CoV-2: Maternal Coronavirus Infections and Pregnancy Outcomes. Arch Pathol Lab Med. 1;144(7):799-805. doi: 10.5858/arpa.2020-0901-SA.
5. Guan W.J., Ni Z.Y., Hu Y., Liang W., Ou С., He J.et al. (2020). Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382:1708-1720. doi:10.1056/NEJMoa2002032.
6. Shkolnyk O.S., Shlemkevych A.M., Malanchuk O.M., Sharhorodska Ye.B., Akopian H.R. (2021). Vplyv SARS-COV-2 na vahitnist ta plid [Impact of SARS-COV-2 on pregnancy and fetus]. Visnyk Ukrainska medychna stomatolohichna akademiia. 21; 2(74):208-213. doi 10.31718/2077-1096.21.2.208. [in Ukrainian].
7. Wang P.H., Lee W.L., Yang S.T., Tsui K.H., Chang C.C., Lee F.K. (2021). The impact of COVID-19 in pregnancy: Part I. Clinical presentations and untoward outcomes of pregnant women with COVID-19. J Chin Med Assoc. 1;84(9):813-820. doi: 10.1097/JCMA.0000000000000595.PMID: 34369462.
8. Hui D.S., Azhar E.І, Madani T.A., Drosten С., Zumla А., Petersen Е. et al. (2020). The continuing 2019 nCoV epidemic threat of novel coronaviruses to global health – The latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis.;91:264-266. https://doi.org/10.1016/j.ijid.2020.01.009.
9. Bai Y., Yao L., Wei T., Tian F., Jin D.Y., Chen L., et al. (2020). Presumed Asymptomatic Carrier Transmission of COVID-19. JAMA. 323(14):1406-1407. doi:10.1001/jama.2020.2565. 10. Jaiswal N., Puri M., Agarwal K., Singh S., Yadav R., Tiwary N., et al. (2021). COVID-19 as an independent risk factor for subclinical placental dysfunction. Eur J Obstet Gynecol Reprod Biol. 259:7-11. doi: 10.1016/j.ejogrb.2021.01.049. Epub 2021 Jan 29.PMID: 33556768.
11. Kannan S., Shaik Syed A.P., Sheeza A., Hemalatha K. (2020). COVID-19 (Novel Coronavirus 2019). Eur Rev Med Pharmacol Sci. 24(4):2006- 2011.
12. Holubovs’ka O.A. (2021). Postkovidnyy syndrom: patohenez ta osnovni napryamy reabilitatsiyi [Synloma after COVID-19: pathogenesis, main directions of rehabilitation] Medychna hazeta ''Zdorov’ya Ukrayiny 21 storichchya''. 3:496. [in Ukrainian].
13. Chen D., Yang H., Cao Y., Cheng W., Duan Т., Fan С. et al. (2020) Expert consensus for managing pregnant women and neonates born to mothers with suspected or confirmed novel coronavirus (COVID‐19) infection. Int. J. Gynecol. Obstet. 149: 130–136. DOI:10.1002/ijgo.13146.
14. Panahi L., Amiri M., Pouy S. (2020). Risks of Novel Coronavirus Disease (COVID-19) in Pregnancy; a Narrative Review. Arch. Acad. Emerg. Med., 8(1): e34.
15. Juusela A., Nazir M., Gimovsky M. (2020) Two cases of coronavirus 2019-related cardiomyopathy in pregnancy. Am. J. Obstet. Gynecol. MFM. 2: 100113. DOI:10.1016/j.ajogmf.2020.100113.
16. Delahoy M.J., Whitaker M., O’Halloran А., Chaі S,J., Daily Р., Alden N. et al. (2020). Characteristics and Maternal and Birth Outcomes of Hospitalized Pregnant Women with Laboratory-Confirmed COVID-19 – COVID-NET, 13 States, March 1-August 22, 2020. MMWR
Morb. Mortal. Wkly Rep. 69(38): 1347–1354. http://dx.doi.org/10.15585/mmwr.mm6938e1.
17. Hayakawa S., Komine‐Aizawa S., Mor G.G. (2020) Covid‐19 pandemic and pregnancy. J. Obstet. Gynaecol. Res., 46: 1958–1966. DOI:10.1111/jog.14384.
18. Elshafeey F., Magdi R., Hindi N. (2020) A systematic scoping review of COVID-19 during pregnancy and childbirth. Int. J. Gynaecol. Obstet, 150(1): 47–52. doi: 10.1002/ijgo.13182.
19. Berghella V., Hughes B. (2020). Coronavirus disease 2019 (COVID-19): pregnancy issues and antenatal care. Аccess mode: https://www.uptodate.com/contents/coronavirus-disease-2019-covid-19-pregnancy-issues.
20. Kostiuk O.O., Shunko Ye.Ye.( 2020). Mama ta dytyna v umovakh svitovoi pandemii koronavirusnoi infektsii. Novi vyklyky dlia systemy okhorony zdorovia [Mother and child in world conditions pandemic of coronavirus infection. New challenges for the healthcare system]. Ukrainskyi zhurnal perynatolohiia i pediatriia. 2:17-26. Аccess mode: http://nbuv.gov.ua/UJRN/perynatology-2020-2-4 [in Ukrainian].